Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
about
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trialDose-dense chemotherapy for breast cancer: what does the future hold?Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study.Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.
P2860
Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Adjuvant dose-dense sequential ...... Oncology Group (HeCOG) study.
@en
Adjuvant dose-dense sequential ...... Oncology Group (HeCOG) study.
@nl
type
label
Adjuvant dose-dense sequential ...... Oncology Group (HeCOG) study.
@en
Adjuvant dose-dense sequential ...... Oncology Group (HeCOG) study.
@nl
prefLabel
Adjuvant dose-dense sequential ...... Oncology Group (HeCOG) study.
@en
Adjuvant dose-dense sequential ...... Oncology Group (HeCOG) study.
@nl
P2093
P2860
P1433
P1476
Adjuvant dose-dense sequential ...... Oncology Group (HeCOG) study.
@en
P2093
Aristotelis Bamias
Christos A Papadimitriou
Eleni Timotheadou
Gerasimos Aravantinos
Pavlos Papakostas
P2860
P304
P356
10.1080/07357900701829785
P577
2008-06-01T00:00:00Z